4//SEC Filing
NEOGENOMICS INC 4
Accession 0001209191-17-029246
$NEOCIK 0001077183operating
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:55 PM ET
Size
10.5 KB
Accession
0001209191-17-029246
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-04-28$7.52/sh+50,000$376,000→ 50,000 totalExercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (50,000 underlying)
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 25,953
Common Stock
- 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying)
Footnotes (4)
- [F1]On March 5, 2014, Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F2]On May 4, 2015, Dr. Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F3]On April 20, 2016, Dr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On April 28, 2017, Dr. Brodie was granted 50,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- May 1, 8:00 PM ET
- Accepted
- May 2, 4:55 PM ET
- Size
- 10.5 KB